Skip to content
ScienceBlog.com
  • Featured Blogs
    • EU Horizon Blog
    • ESA Tracker
    • Experimental Frontiers
    • Josh Mitteldorf’s Aging Matters
    • Dr. Lu Zhang’s Gondwanaland
    • NeuroEdge
    • NIAAA
    • SciChi
    • The Poetry of Science
    • Wild Science
  • Topics
    • Brain & Behavior
    • Earth, Energy & Environment
    • Health
    • Life & Non-humans
    • Physics & Mathematics
    • Social Sciences
    • Space
    • Technology
  • Our Substack
  • Follow Us!
    • Bluesky
    • Threads
    • FaceBook
    • Google News
    • Twitter/X
  • Contribute/Contact

Omicron variant

Ohio State logo

SARS-CoV-2 BA.2.86 is less resistant to vaccine, but may be a problem in the lung

The Omicron subvariants BA.1, BA.4, BA.5 as well as Q.1.1 have a high number of mutations in the spike protein. Some of these mutations are escape mutations that allow the virus to escape neutralization by antibodies. In addition, resistance to biotechnologically produced antibodies, which are administered to high-risk patients as a preventive measure or as therapy for a diagnosed SARS-CoV-2 infection, is also developing. Omicron sub-lineage BQ.1.1 is the first variant resistant to all antibody therapies currently approved by the EMA (European Medicines Agency) and/or FDA (US Food and Drug Administration).

New Omicron subvariant BQ.1.1 resistant to all therapeutic antibodies

Substack subscription form sign up

Comments

  • Norwood johnson on Electrons in New Crystals Behave as If They Live in Four Dimensions
  • ScienceBlog.com on Hidden Geometry Could Finally Fix Quantum Computers
  • Theo Prinse on America Is Going Back to the Moon. This Time, It Plans to Stay
  • george w on Hidden Geometry Could Finally Fix Quantum Computers
  • Tom Hughes on Years of Exercise, Blood Pressure Drugs Failed to Slow Cognitive Decline in Seniors at Dementia Risk
© 2026 ScienceBlog.com | Follow our RSS / XML feed